Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

31.07.18	PFIZER REPORTS SECOND-QUARTER 2018 RESULTS (Businesswire)
31.07.18	Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA™ (trastuzumab) (Businesswire)
31.07.18	Pfizer's New Report Shows How Behavioural Science Can Help Boost Preventative Healthcare Measures (PR Newswire)
31.07.18	Pfizer's New Report Shows How Behavioural Science Can Help Boost Preventative Healthcare Measures (PR Newswire)
26.07.18	Biotech Stocks Facing FDA Decision In August (RTTNews)
25.07.18	Pfizer To Build Sterile Injectable Facility In Michigan, Create About 450 Jobs (RTTNews)
24.07.18	Pfizer to Build Cutting-Edge Sterile Injectable Facility in Michigan, Investing Nearly Half a Billion Dollars in U.S. Manufacturing, Creating More than 450 Jobs (Businesswire)
23.07.18	Leap Therapeutics To Collaborate With Merck, Pfizer To Evaluate TRX518 (RTTNews)
23.07.18	FDA Nod For AGIO's AML Drug, 2nd Neupogen Biosim Gets Green Light, BGNE On Watch (RTTNews)
20.07.18	U.S. FDA Approves Pfizer’s Biosimilar NIVESTYM™ (filgrastim-aafi) (Businesswire)
18.07.18	Pfizer And Lilly Announce Positive Results From Phase 3 Trial Of Tanezumab (RTTNews)
18.07.18	Pfizer And Lilly Announce Positive Top-Line Results From Phase 3 Trial Of Tanezumab For The Treatment Of Osteoarthritis (OA) Pain (Businesswire)
16.07.18	Pfizer Initiates Pivotal Phase 3 Program for Investigational Hemophilia B Gene Therapy (Businesswire)
13.07.18	U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC) (Businesswire)
11.07.18	Pfizer To Organize Into Three Businesses - Quick Facts (RTTNews)
11.07.18	Pfizer to Organize for Future Growth (Businesswire)
11.07.18	Pfizer To Defer Price Increases (RTTNews)
11.07.18	Pfizer’s Announces It Will Defer Company’s Price Increases (Businesswire)
10.07.18	Trump Attacks Pfizer For Drug Price Hikes (RTTNews)
03.07.18	Remember When Was The Last Time A New Alzheimer's Drug Was Approved? (RTTNews)
28.06.18	XELJANZ® (tofacitinib citrate) Receives Marketing Authorisation in the European Union for Active Psoriatic Arthritis (Businesswire)
28.06.18	Pfizer Declares 34-Cent Third-Quarter 2018 Dividend (Businesswire)
28.06.18	ACRX Gets EC Nod, AQXP Tanks As LEADERSHIP 301 Fails, ZSAN Catches Eye (RTTNews)
27.06.18	FDA Grants Priority Review For Pfizer's NDA For Glasdegib - Quick Facts (RTTNews)
27.06.18	U.S. FDA Grants Priority Review for Pfizer’s New Drug Application for Glasdegib in Patients with Previously Untreated Acute Myeloid Leukemia (Businesswire)
25.06.18	Pfizer Records Overall Survival In Metastatic Breast Cancer Study Using Ibrance (RTTNews)
25.06.18	Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE® (Palbociclib) in HR+, HER2- Metastatic Breast Cancer (Businesswire)
21.06.18	In The Spotlight: Sangamo Therapeutics (RTTNews)
19.06.18	Pfizer Invites Public To View And Listen To Webcast Of July 31 Conference Call With Analysts (Businesswire)
12.06.18	Pfizer Announces Extension of Zithromax® Antibiotic Donation Program through 2025 to Help Eliminate World’s Leading Infectious Cause of Blindness (Businesswire)
07.06.18	Pfizer Granted FDA Priority Review For Talazoparib - Quick Facts (RTTNews)
07.06.18	U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Talazoparib for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation (Businesswire)
06.06.18	Pfizer To Expand Venture Investing With $600 Mln Commitment To Pfizer Venture (RTTNews)
06.06.18	Pfizer to Expand Venture Investing with $600 Million Commitment to Pfizer Ventures (Businesswire)
04.06.18	Dacomitinib Shows More than Seven-Month Improvement in Overall Survival Compared to an Established Therapy in Advanced NSCLC with EGFR-Activating Mutations (Businesswire)
01.06.18	Pfizer Gets Positive CHMP Opinion For Oncology Biosimilar Trazimera (RTTNews)
01.06.18	Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, TRAZIMERA™ (trastuzumab) (Businesswire)
01.06.18	Intelligent Investor - June 1 (RTTNews)
31.05.18	CRSP Falls On Clinical Hold, PFE Gets FDA Nod, ARWR To Report Data In Nov. (RTTNews)
31.05.18	Pfizer:FDA Oks XELJANZ To Treat Moderately To Severely Active Ulcerative Colitis (RTTNews)
29.05.18	Pfizer: Xalkori Gets FDA Breakthrough Therapy Designation In Two New Indications (RTTNews)
24.05.18	Pfizer To Pay $23.85 Mln To Resolve Kickback Claims: DoJ (RTTNews)
23.05.18	Pfizer: FDA Grants Breakthrough Therapy Designation For Tafamidis - Quick Facts (RTTNews)
23.05.18	FDA Grants Breakthrough Therapy Designation for Tafamidis for the Treatment of Patients with Transthyretin Cardiomyopathy (Businesswire)
22.05.18	A Study Analyzing Observational Data Shows Real-World Effectiveness of Prevnar® 13 in Adults Age 65+ (Businesswire)
22.05.18	Pfizer Begins Phase 1/2 Study To Evaluate Respiratory Syncytial Virus Vaccine (RTTNews)
22.05.18	Pfizer Begins a Phase 1/2 Study to Evaluate Respiratory Syncytial Virus (RSV) Vaccine (Businesswire)
21.05.18	GlaxoSmithKline Reports EU Marketing Authorisation For Juluca To Treat HIV (RTTNews)
17.05.18	Pfizer: Lyrica Oral Solution CV Phase 3 Trial Meets Primary Endpoint (RTTNews)
17.05.18	LYRICA® (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V

mehr

18.12.24		Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten
18.12.24		Pluszeichen in Europa: STOXX 50 letztendlich fester
18.12.24		Minuszeichen in Zürich: SMI legt letztendlich den Rückwärtsgang ein
18.12.24		Börse Zürich in Rot: SPI schliesst in der Verlustzone
18.12.24		Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester
18.12.24		Freundlicher Handel in London: FTSE 100 notiert zum Ende des Mittwochshandels im Plus
18.12.24		Zuversicht in Frankfurt: Zum Ende des Mittwochshandels Pluszeichen im TecDAX
18.12.24		Aufschläge in Frankfurt: SDAX steigt zum Handelsende

18.12.24

Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten

18.12.24

Pluszeichen in Europa: STOXX 50 letztendlich fester

18.12.24

Minuszeichen in Zürich: SMI legt letztendlich den Rückwärtsgang ein

18.12.24

Börse Zürich in Rot: SPI schliesst in der Verlustzone

18.12.24

Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester

18.12.24

Freundlicher Handel in London: FTSE 100 notiert zum Ende des Mittwochshandels im Plus